arrow
S

Sung-Soo Park

seoul st mary's hospital
H指数:22
被引数:2,811

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term efficacy and safety of romiplostim plus immunosuppressive therapy as first-line treatment in patients with aplastic anaemia: 2-year interim analysis of observational study of two clinical trials

罗米司亭联合免疫抑制疗法作为再生障碍性贫血患者的一线治疗的长期疗效和安全性:两项临床试验的观察性研究的2年中期分析

2026-08-210
OAAI
Real-world effectiveness of bortezomib maintenance following VMP induction in transplant-ineligible multiple myeloma: a target trial emulation study

移植不适格多发性骨髓瘤患者中硼替佐米维持治疗在VMP诱导后的真实世界有效性:一项目标试验模拟研究

2026-03-230
OAAI
Correction: Metabolic Surgery for Obese Type 2 Diabetes: Korean Multicenter Cohort Study

更正:代谢手术用于肥胖2型糖尿病:韩国多中心队列研究

2025-12-120
OAAI
Metabolic Surgery for Obese Type 2 Diabetes: Korean Multicenter Cohort Study

肥胖2型糖尿病的代谢手术:韩国多中心队列研究

2025-11-130
OAAI
BCR::ABL1-positive acute lymphoblastic leukemia as a high-risk feature of central nervous system relapse after allogeneic hematopoietic cell transplantation

BCR::ABL1阳性的急性淋巴细胞白血病是异基因造血细胞移植后中枢神经系统复发的危险因素。

2025-10-060
OA
Ponatinib Monotherapy in Adult Patients with Relapsed or Refractory Philadelphia-Positive Acute Lymphoblastic Leukemia: A Real-World Retrospective Analysis Including Measurable Residual Disease Relapse

波纳替尼单药治疗成人复发性或难治性费城染色体阳性急性淋巴细胞白血病的真实世界回顾性分析:包括可测量微小残留病复发情况

2025-10-010
OAAI
Outcome of second allogeneic hematopoietic cell transplantation in adult patients with relapsed B-cell acute lymphoblastic leukemia in the era of new immunotherapeutic agents

成人复发B细胞急性淋巴细胞白血病患者在新免疫治疗药物时代的第二次异基因造血细胞移植结局

2025-06-170
PRE
Feasibility of a Total Body Irradiation-Augmented Reduced-Toxicity Conditioning Regimen with an Antithymocyte Globulin/Post-Transplantation Cyclophosphamide Combination for Haploidentical Donor Transplantation in Adult Acute Lymphoblastic Leukemia

异基因供者移植中成人急性淋巴细胞白血病采用抗胸腺细胞球蛋白/移植后环磷酰胺联合方案增敏的全身体外照射增强减毒预处理方案的安全性评估

2025-05-240
PRE
Efficacy and Safety of Bispecific T-Cell Engagers in Relapsed/ Refractory Multiple Myeloma: A Real-World Data-Based Case-Controlled Study

双特异性T细胞接合器治疗复发/难治性多发性骨髓瘤的疗效和安全性: 一项基于真实世界数据的病例对照研究

2025-02-010
PRE
Real-World Efficacy and Safety of Teclistamab for Patients with Released or Refractory Multiple Myeloma: Korean, Nationwide, Retrospective Analysis of an Named Patient Program

托西卡玛单抗在复发或难治性多发性骨髓瘤患者中的真实世界疗效与安全性:韩国全国性回顾性分析(基于指定患者用药计划)

BLOOD
IF23.1
2024-11-050
PRE